We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.65B
AUM Growth
+$399M
Cap. Flow
+$23.1M
Cap. Flow %
0.63%
Top 10 Hldgs %
29.99%
Holding
549
New
63
Increased
188
Reduced
161
Closed
15

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$21.6M
2
TAIL icon
Cambria Tail Risk ETF
TAIL
+$11.3M
3
KEYS icon
Keysight
KEYS
+$4.77M
4
APD icon
Air Products & Chemicals
APD
+$3.48M
5
FISV
Fiserv Inc
FISV
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 15.58%
3 Financials 11.72%
4 Consumer Staples 9.52%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVE icon
226
iShares S&P 500 Value ETF
IVE
$49B
$823K 0.02%
6,428
+127
+2% +$15.4K
VRTX icon
227
Vertex Pharmaceuticals
VRTX
$121B
$817K 0.02%
3,455
-42
-1% -$9.64K
HSCZ icon
228
iShares Currency Hedged MSCI EAFE Small-Cap ETF
HSCZ
$239M
$808K 0.02%
25,100
-2,000
-7% -$60.8K
OLED icon
229
Universal Display
OLED
$3.68B
$804K 0.02%
3,500
VIG icon
230
Vanguard Dividend Appreciation ETF
VIG
$111B
$796K 0.02%
5,641
+377
+7% +$51.1K
SPG icon
231
Simon Property Group
SPG
$74.4B
$789K 0.02%
9,247
-50
-0.5% -$3.82K
BIL icon
232
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$781K 0.02%
8,535
-2,130
-20% -$195K
IWD icon
233
iShares Russell 1000 Value ETF
IWD
$82.2B
$779K 0.02%
5,698
-187
-3% -$24K
EW icon
234
Edwards Lifesciences
EW
$49.6B
$763K 0.02%
8,360
-586
-7% -$48.6K
SO icon
235
Southern Company
SO
$109B
$754K 0.02%
12,266
-50
-0.4% -$3.01K
ELV icon
236
Elevance Health
ELV
$81.5B
$744K 0.02%
2,318
+23
+1% +$7.06K
CBOE icon
237
Cboe Global Markets
CBOE
$32.5B
$731K 0.02%
7,847
XYZ
238
Block Inc
XYZ
$48.4B
$730K 0.02%
3,355
VO icon
239
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$729K 0.02%
14,096
+520
+4% +$25.2K
TIP icon
240
iShares TIPS Bond ETF
TIP
$14.5B
$701K 0.02%
5,488
DTE icon
241
DTE Energy
DTE
$29.5B
$695K 0.02%
6,729
CAH icon
242
Cardinal Health
CAH
$53.9B
$694K 0.02%
12,964
-296
-2% -$15.4K
TT icon
243
Trane Technologies
TT
$100B
$668K 0.02%
4,600
VYM icon
244
Vanguard High Dividend Yield ETF
VYM
$80.9B
$654K 0.02%
7,149
+103
+1% +$8.95K
CSX icon
245
CSX Corp
CSX
$93.4B
$641K 0.02%
21,183
+108
+0.5% +$3.1K
VB icon
246
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$636K 0.02%
3,265
ACWI icon
247
iShares MSCI ACWI ETF
ACWI
$32.5B
$635K 0.02%
7,000
BHP icon
248
BHP
BHP
$215B
$633K 0.02%
10,868
VEA icon
249
Vanguard FTSE Developed Markets ETF
VEA
$229B
$632K 0.02%
13,381
+210
+2% +$9.24K
RBC icon
250
RBC Bearings
RBC
$17.4B
$630K 0.02%
3,520

Similar funds

Gofen & Glossberg's Q4 2020 Portfolio in Review

As of Q4 2020, Gofen & Glossberg held 549 positions worth $3.65B, up 12% from $3.25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gofen & Glossberg's Q4 2020 filing shows 63 new, 188 increased, 161 reduced and 15 closed positions. Its largest new stake was Constellation Brands: 12,448 shares worth $2.73M. The largest sale was Unilever NV New York Registry Shares, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q4 2020 buy was Constellation Brands: 12,448 shares worth $2.73M.
  • Gofen & Glossberg added most to Unilever in Q4 2020, an estimated $21.6M increase.
  • Gofen & Glossberg's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $3.52M.
  • Gofen & Glossberg fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $21.5M.
  • Gofen & Glossberg's ten largest holdings make up 30% of its $3.65B portfolio in Q4 2020.
  • Gofen & Glossberg opened 63 new positions and closed 15 in Q4 2020.
  • Gofen & Glossberg's portfolio value rose 12% quarter-over-quarter to $3.65B.

Based on Gofen & Glossberg's 13F filing for Q4 2020, filed 15 Jan 2021.